| 000 | 00924 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250513205540.0 | ||
| 264 | 0 | _c20000616 | |
| 008 | 200006s 0 0 eng d | ||
| 022 | _a0258-851X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKaiser, H E | |
| 245 | 0 | 0 |
_aGrowth inhibitors in the treatment of malignant neoplasms. _h[electronic resource] |
| 260 |
_bIn vivo (Athens, Greece) _c |
||
| 300 |
_a287-96 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAscorbic Acid _xpharmacology |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferons _xpharmacology |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aRetinoids _xpharmacology |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta _xpharmacology |
| 700 | 1 | _aKrenn, M | |
| 700 | 1 | _aBodey, B | |
| 700 | 1 | _aBodey, B | |
| 773 | 0 |
_tIn vivo (Athens, Greece) _gvol. 14 _gno. 1 _gp. 287-96 |
|
| 999 |
_c10710417 _d10710417 |
||